In the last week, Pharma has been flat. The past year has been better, since the industry has gained 13% in that time. Looking forward, earnings are forecast to grow by 21% annually.
Has the U.S. Pharma Industry valuation changed over the past few years?
Date | Market Cap | Revenue | Earnings | PE | Absolute PE | PS |
---|---|---|---|---|---|---|
Thu, 25 Apr 2024 | US$1.8t | US$357.7b | US$29.8b | 20.4x | 60.9x | 5.1x |
Sat, 23 Mar 2024 | US$1.9t | US$355.3b | US$22.6b | 19.8x | 82.6x | 5.3x |
Mon, 19 Feb 2024 | US$1.9t | US$355.0b | US$23.9b | 28.3x | 79.6x | 5.4x |
Wed, 17 Jan 2024 | US$1.8t | US$375.2b | US$33.9b | 27.6x | 52.6x | 4.7x |
Fri, 15 Dec 2023 | US$1.7t | US$375.1b | US$33.9b | 27x | 49.6x | 4.5x |
Sun, 12 Nov 2023 | US$1.6t | US$375.5b | US$34.1b | 26.5x | 47.6x | 4.3x |
Tue, 10 Oct 2023 | US$1.7t | US$381.8b | US$43.8b | 18.5x | 38.4x | 4.4x |
Thu, 07 Sep 2023 | US$1.7t | US$381.8b | US$43.9b | 19.2x | 38.8x | 4.5x |
Sat, 05 Aug 2023 | US$1.7t | US$379.3b | US$43.5b | 21.5x | 38.7x | 4.4x |
Mon, 03 Jul 2023 | US$1.8t | US$392.8b | US$60.2b | 18.7x | 29.2x | 4.5x |
Wed, 31 May 2023 | US$1.7t | US$393.0b | US$60.6b | 17.8x | 27.4x | 4.2x |
Fri, 28 Apr 2023 | US$1.7t | US$402.7b | US$63.2b | 17.1x | 26.1x | 4.1x |
Sun, 26 Mar 2023 | US$1.6t | US$401.2b | US$69.4b | 14.7x | 22.4x | 3.9x |
Tue, 21 Feb 2023 | US$1.6t | US$401.8b | US$68.4b | 18.8x | 23.9x | 4.1x |
Thu, 19 Jan 2023 | US$1.7t | US$403.7b | US$70.6b | 17.6x | 23.9x | 4.2x |
Sat, 17 Dec 2022 | US$1.7t | US$403.7b | US$70.7b | 16.7x | 24.6x | 4.3x |
Mon, 14 Nov 2022 | US$1.7t | US$403.6b | US$71.1b | 12.9x | 23.6x | 4.2x |
Wed, 12 Oct 2022 | US$1.6t | US$403.0b | US$71.3b | 12.4x | 21.9x | 3.9x |
Fri, 09 Sep 2022 | US$1.6t | US$403.0b | US$71.3b | 13.7x | 22.3x | 4x |
Sun, 07 Aug 2022 | US$1.6t | US$403.3b | US$69.5b | 19.3x | 23.5x | 4.1x |
Tue, 05 Jul 2022 | US$1.7t | US$392.4b | US$65.1b | 21.9x | 26x | 4.3x |
Thu, 02 Jun 2022 | US$1.7t | US$392.5b | US$64.8b | 21.5x | 25.7x | 4.2x |
Sat, 30 Apr 2022 | US$1.6t | US$380.0b | US$61.3b | 20.5x | 26.8x | 4.3x |
Mon, 28 Mar 2022 | US$1.6t | US$373.8b | US$60.3b | 22.3x | 27.3x | 4.4x |
Wed, 23 Feb 2022 | US$1.5t | US$373.4b | US$59.2b | 21x | 25.4x | 4x |
Fri, 21 Jan 2022 | US$1.6t | US$361.3b | US$37.7b | 23.3x | 41.8x | 4.4x |
Sun, 19 Dec 2021 | US$1.6t | US$361.1b | US$38.1b | 22.6x | 42.9x | 4.5x |
Tue, 16 Nov 2021 | US$1.6t | US$360.6b | US$38.5b | 24.1x | 41.4x | 4.4x |
Thu, 14 Oct 2021 | US$1.5t | US$337.7b | US$24.8b | 21.5x | 59.7x | 4.4x |
Sat, 11 Sep 2021 | US$1.5t | US$338.7b | US$25.4b | 18.4x | 60.1x | 4.5x |
Mon, 09 Aug 2021 | US$1.6t | US$338.5b | US$25.8b | 20.9x | 61.2x | 4.7x |
Sun, 02 May 2021 | US$1.4t | US$315.6b | US$19.6b | 18.8x | 71.9x | 4.5x |
71.9x
How does U.S. Pharma compare with similar industries?
US Market | 1.21% | |
Healthcare | 1.41% | |
Pharma | 0.083% | |
Pharma | 0.083% |
Which companies have driven the market over the last 7 days?
Company | Last Price | 7D | 1Y | Valuation | |
---|---|---|---|---|---|
JNJ Johnson & Johnson | US$148.53 | 2.6% +US$9.1b | -8.7% | PE18.7x | |
PFE Pfizer | US$26.27 | 3.3% +US$4.8b | -32.0% | PE69.7x | |
MRK Merck | US$127.00 | 1.3% +US$4.1b | 12.0% | PE881.4x | |
BMY Bristol-Myers Squibb | US$48.86 | 2.1% +US$2.1b | -28.2% | PE12.3x | |
VTRS Viatris | US$11.55 | 4.1% +US$534.4m | 26.9% | PE250.8x |